Ownership Summary
According to SEC filings for the period ending December 2025, Jin Medical International Ltd. (NASDAQ:ZJYL) is held by 9 institutional firms.
- The percentage of Jin Medical International owned by institutions changed from 0.2% in September 2025 to 0.3% in December 2025, marking a slight up trend.
- The company experienced a 134.76% quarterly change in institutional shares held, alongside an unavailable change in total owners annually.
- Of these 9 institutional investors, 6 increased their holdings in Jin Medical International, while 2 of them reduced positions, and 1 investors maintained their exposure.
- The total number of shares held by institutions in Jin Medical International increased to 402.45K as of December 2025, a net change of up by 231.02K shares quarter on quarter, and up 395.14K shares year over year.
- CITADEL ADVISORS LLC's holding of 117.79K shares as of December 31, 2025 makes it the primary institutional investor in Jin Medical International, owning 0.10% of the stock.
- Among the most significant buyers of Jin Medical International during December 2025 were CITADEL ADVISORS LLC (117.79K), JANE STREET GROUP, LLC (50.92K), RENAISSANCE TECHNOLOGIES LLC (40.00K), XTX Topco Ltd (28.64K), TWO SIGMA SECURITIES, LLC (21.97K).
- Leading sellers of Jin Medical International stock in December 2025 included UBS Group AG (37.20K), MORGAN STANLEY (100).
- The top 9 institutional holders of Jin Medical International for the quarter ending December 2025 included CITADEL ADVISORS LLC (117.79K), GEODE CAPITAL MANAGEMENT, LLC (106.54K), JANE STREET GROUP, LLC (50.92K), RENAISSANCE TECHNOLOGIES LLC (40.00K), OSAIC HOLDINGS, INC. (32.00K), XTX Topco Ltd (28.64K), TWO SIGMA SECURITIES, LLC (21.97K), UBS Group AG (4.49K), MORGAN STANLEY (100).